Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia.

"Declarations Ethics approval and consent to participateThis study was approved by the Ethics Committee of Shanghai Tenth People’s Hospital (22K127) and all study participants provided written informed consent. Consent for publicationWritten informed consent for publication was obtained from all participants. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This work was supported by the Chinese National Natural Science Foundation (82170521), Shanghai Natural Science Foundation of China (21ZR1449500), Foundation of Shanghai Municipal Health Commission (202140263), the Fundamental Research Funds for Central Universities (NO.22120190211), Foundation of Chongming (CKY2021-21, CKY2020-29), and Clinical Research Plan of SHDC (SHDC2020CR4065)."